Exelixis, Inc. (EXEL) Social Stream



Exelixis, Inc. (EXEL): $20.79

-0.15 (-0.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EXEL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Exelixis Inc (EXEL) Price Targets From Analysts

Use the tables below to see what analysts covering Exelixis Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 12 $52 $22 $31.416 $22.89 37.25%
2022-01-06 12 $52 $22 $31.25 $22.89 36.52%
2022-02-18 12 $52 $22 $31.083 $22.89 35.79%
2022-02-22 12 $42 $22 $30.333 $22.89 32.52%
2022-02-23 12 $42 $22 $30.166 $22.89 31.79%
2022-03-18 12 $42 $22 $29.272 $22.89 27.88%

The Trend in the Analyst Price Target


Over the past 22 months, EXEL's average price target has gone down $0.58.

EXEL reports an average of 56.17% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 15 37 26 31.460 25.11 25.29%
2021-07-03 14 37 21 29.930 18.26 63.91%
2021-11-04 12 52 22 31.416 18.93 65.96%
2022-01-06 12 52 22 31.250 18.29 70.86%
2022-01-13 12 52 22 31.083 17.77 74.92%

EXEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 8 2 2 0 0 12

The Trend in the Broker Recommendations


EXEL's average broker recommendation rating improved by 0.5 over the prior 26 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • EXEL has a lower variance in analysts' estimates than -584.14% of all US stocks.
  • In terms of how Exelixis Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 722.64% of that group.
  • In the context of Healthcare stocks, Exelixis Inc's upside potential (average analyst target price relative to current price) is higher than 212.45% of them.
  • In the context of Business Services stocks, Exelixis Inc's average analyst price target is higher than 227.14% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Business Services industry with the ratings most similar to Exelixis Inc are WSC, HRI, and FTAI.

What is the outlook for EXEL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4622 seconds.